Early Onset Obesity and Risk of Metabolic Syndrome Among Chilean Adolescents
ORIGINAL RESEARCH — Volume 14 — October 12, 2017
PEER REVIEWED
A flow diagram describes 1) participant recruitment into an infancy iron deficiency anemia (IDA) preventive trial (N = 1,798) or a neuromaturation study (n = 135); 2) randomization group for those in the IDA preventive trial (infants without iron deficiency anemia randomized to high iron [n = 782], low iron [n = 432], usual nutrition [n = 584] ); 3) completion of the infancy studies at age 6 to 12 months (preventive trial, n = 1,657 [high iron, n = 718; low iron, n = 405; usual nutrition, n = 534] , or neuromaturation study, n = 135); 4) the sample for the 5-year follow up (n = 888) recruited from high iron, usual nutrition group, and neuromaturation study, from which the 5) adolescent cardiovascular disease risk study was drawn (n = 677), and 6) the analytic sample for the study of the relationship between early onset obesity and risk of metabolic syndrome (n = 673) after participants without complete data (n = 4) were excluded.
Figure.
Flow of participants in study on relationship between early onset obesity and metabolic syndrome risk in adolescence, Santiago, Chile, 2009–2012. Participants were drawn from a larger study of infancy iron-deficiency anemia.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.